Evidence map›Paper›PMID 42268632›Full record

ArticleJAMA2026

Female Clinical Resilience Despite Pathologic Risk in Alzheimer Disease.

Kaitlin B Casaletto, Dena B Dubal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaitlin B CasalettoDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco.
Dena B DubalDepartment of Neurology and Weill Institute for Neurosciences, University of California, San Francisco.

Funding

Mechanisms of X-Chromosome-dependent Sex Difference inAlzheimers DiseaseRF1AG068325 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBAL, DENA BOU · 2020 to 2020
$2.3M
Sex Differences in Epigenetic Parent-of-X Origin and Alzheimer's DiseaseRF1AG079176 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBAL, DENA BOU · 2022 to 2022
$1.7M
Sex Differences in Epigenetic Parent-of-X Origin and Alzheimer's DiseaseR01AG079176 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Dena Bou Dubal · 2025 to 2026
$976k
Mechanisms of X-Chromosome-dependent Sex Difference inAlzheimers DiseaseR01AG068325 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBAL, DENA BOU · 2024 to 2024
$526k
NIA NIH HHS R01 AG068325NIA NIH HHS R01 AG079176NIA NIH HHS RF1 AG068325NIA NIH HHS RF1 AG079176Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42268632
PMCPMC13685745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.